The gut microbiota is now recognised as a key player in digestion, immunity and physiological balance.
Modulating it is a strategic lever for the development of high value-added nutritional products.
La diversification maîtrisée des activités
L’intégration progressive de la chaîne de valeur pour des ingrédients robustes et innovants
L'internationalisation progressive.
Within the Proxis Développement group, Bioprox Healthcare is our nutrition and health division, specialising in the industrial fermentation of microorganisms. As a recognised European stakeholder, this subsidiary supports manufacturers in the fields of:
La diversification maîtrisée des activités
L’intégration progressive de la chaîne de valeur pour des ingrédients robustes et innovants
L'internationalisation progressive.
dietary supplements
pet food
functional food
cosmetics
As a CDMO (Contract Development and Manufacturing Organisation), Bioprox Healthcare acts as a true industrial partner: from process optimisation in the laboratory through to the delivery of freeze-dried biomass ready for formulation.
BIOPROX HEALTHCARE in pictures
Bioprox Healthcare offers its cultures in the form of pure or standardised freeze-dried biomass, available as single-strain or multi-strain blends. Customised formulations are also available to meet your specifications.
The properties of the strains have been validated by preclinical studies demonstrating their resilience during the early stages of digestion and their diverse functional activities.
Unlike live bacteria, postbiotics are non-living and offer several key advantages: increased stability during food processing, and fewer regulatory constraints.
Clinical trials have demonstrated their benefits in a variety of areas in both humans and animals. The quality of the postbiotic product can be easily verified by flow cytometry in a standard quality control laboratory.
Bioprox Healthcare is one of the few European companies to have mastered the industrial production of high-concentration freeze-dried postbiotics, with stability standards among the highest on the market.
Bioprox Healthcare oversees every critical stage of the process in-house:
industrial fermentation
centrifugation
freeze-drying
and bespoke probiotic formulation
La diversification maîtrisée des activités
L’intégration progressive de la chaîne de valeur pour des ingrédients robustes et innovants
L'internationalisation progressive.
The industrial site, certified to ISO 9001 and FSSC 22000, is equipped with large-capacity fermenters and high-performance freeze-drying equipment, with processes carefully designed to guarantee the efficacy and stability of bioproducts.
A pilot unit ensures the safe transition of processes from the laboratory to the industrial scale. Upscaling is a critical step in ensuring reproducibility and quality.
The R&D laboratory is supported by a team of PhDs, engineers and technicians specialising in microbiology, molecular biology and genomic characterisation, with a constant aim: to improve product yields, concentrations and stability.
In addition to its range of cultures, Bioprox Healthcare offers industrial contract manufacturing services for third parties, specialising in the optimisation and production of its clients’ proprietary strains. A confidential service, tailored to brands wishing to outsource their production without transferring their know-how.
"
Our industrial site in Noyant is undergoing a major transformation. This expansion is essential to support the average annual growth of 30% observed over the last decade. It demonstrates our commitment to meeting market demands with expertise — by combining mastery of industrial processes, cutting-edge microbiological expertise and close collaboration with our clients. "
-1s.webp)
Eric de Mol
Director of Bioprox Healthcare
Bioprox Healthcare is one of the nine areas of expertise within the Proxis Développement group. Its expertise in the industrial fermentation of microorganisms for nutrition and well-being forms part of a coherent group strategy, with strong synergies:
s.webp)
